STOCK TITAN

[8-K] Evolus, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Evolus, Inc. reported a material event on September 8, 2025 via a Current Report on Form 8-K noting two procedural disclosures.

First, the filing references an Employment Agreement described as Exhibit 10.11 to the company's Form S-1 filed January 25, 2018, and states a full copy of that Employment Agreement will be filed as an exhibit to the company's Quarterly Report for the quarter ended September 30, 2025. Second, Evolus furnished a press release as Exhibit 99.1 announcing certain matters described elsewhere in the filing; the exhibit is furnished but not "filed" for Section 18 liability purposes.

The current report contains procedural exhibit references and timing for later exhibit filings but does not include substantive details of the employment terms or the press release text within the body of the filing.

Evolus, Inc. ha comunicato un evento rilevante il 8 settembre 2025 tramite un Current Report on Form 8-K che segnala due divulgazioni di procedura.

In primo luogo, il deposito fa riferimento a un Contratto di Lavoro descritto come Allegato 10.11 al modulo S-1 della società presentato il 25 gennaio 2018, e afferma che una copia completa di quel Contratto di Lavoro sarà depositata come allegato al report trimestrale per il trimestre chiuso il 30 settembre 2025. In secondo luogo, Evolus ha fornito un comunicato stampa come Exhibit 99.1 annunciando determinate questioni descritte altrove nel deposito; l’esibizione è fornita ma non è filed per fini di responsabilità ai sensi della Sezione 18.

Il current report contiene riferimenti procedurali agli exhibit e tempi per ulteriori depositi, ma non include dettagli sostanziali sui termini di impiego o sul testo del comunicato stampa all'interno del corpo del deposito.

Evolus, Inc. informó un hecho material el 8 de septiembre de 2025 a través de un Current Report on Form 8-K que señala dos divulgaciones de procedimiento.

En primer lugar, la presentación hace referencia a un Acuerdo de Empleo descrito como el Anexo 10.11 al formulario S-1 de la compañía presentado el 25 de enero de 2018, y afirma que una copia completa de ese Acuerdo de Empleo se presentará como anexo al informe trimestral para el trimestre terminado el 30 de septiembre de 2025. En segundo lugar, Evolus facilitó un comunicado de prensa como Exhibit 99.1 anunciando ciertos asuntos descritos en otro lugar de la presentación; el anexo se facilita pero no se "presenta" para fines de responsabilidad de la Sección 18.

El informe actual contiene referencias a los anexos procedimentales y el calendario para presentaciones de anexos posteriores, pero no incluye detalles sustantivos de los términos de empleo ni del texto del comunicado de prensa dentro del cuerpo de la presentación.

Evolus, Inc.는 2025년 9월 8일 에 중요한 사건을 현재 보고서인 Form 8-K를 통해 보고했으며, 두 가지 절차적 공시를 주목합니다.

첫째, 제출서는 회사의 2018년 1월 25일에 제출된 Form S-1의 부록 10.11로 설명된 고용 계약을 참조하며, 이 고용 계약의 전체 사본이 2025년 9월 30일 분기말에 해당하는 분기 보고서의 부록으로 제출될 것이라고 명시합니다. 둘째, Evolus는 해당 서류에 기재된 일부 사항을 발표하는 Exhibit 99.1의 보도자료를 제공했습니다; 이 부속서는 제공되지만 제18조 책임 목적상 "파일링"되지는 않습니다.

현재 보고서는 절차적 부속서 참조와 후속 부속서 제출 시기를 포함하고 있지만 고용 조건의 실질적 세부사항이나 본문 내의 보도자료 텍스트는 포함하고 있지 않습니다.

Evolus, Inc. a annoncé un fait material le 8 septembre 2025 via un Current Report on Form 8-K indiquant deux divulgations procédurales.

Premièrement, le dépôt fait référence à un Contrat de travail décrit comme l’Exhibit 10.11 du formulaire S-1 de la société déposé le 25 janvier 2018, et affirme qu’une copie complète de ce Contrat de travail sera déposée comme pièce jointe au rapport trimestriel pour le trimestre se terminant le 30 septembre 2025. Deuxièmement, Evolus a fourni un communiqué de presse en tant que Exhibit 99.1 annonçant certains points décrits ailleurs dans le dépôt; l’exposition est fournie mais n’est pas « déposée » à des fins de responsabilité en vertu de la Section 18.

Le rapport actuel contient des références d’exhibits procéduraux et le calendrier des dépôts ultérieurs, mais ne comprend pas les détails substantiels des termes d’emploi ni le texte du communiqué de presse dans le corps du dépôt.

Evolus, Inc. meldete am 8. September 2025 eine materielle Angelegenheit über einen Current Report on Form 8-K, der zwei verfahrensrechtliche Offenlegungen festhält.

Erstens verweist die Einreichung auf eine Anstellungsvereinbarung, beschrieben als Exhibit 10.11 des Unternehmens-Formulars S-1, das am 25. Januar 2018 eingereicht wurde, und erklärt, dass eine vollständige Kopie dieser Anstellungsvereinbarung als Anhang dem Quartalsbericht für das zum 30. September 2025 endende Zeitraum beigefügt wird. Zweitens stellte Evolus eine Pressemitteilung als Exhibit 99.1 zur Verfügung, die bestimmte dort anderswo in der Einreichung beschriebene Angelegenheiten ankündigt; der Anhang wird zwar bereitgestellt, ist aber nicht für Abschnitt 18 Haftungszwecke "eingegeben".

Der aktuelle Bericht enthält verfahrensbezogene Verweisungen auf Anhänge und den Zeitplan für spätere Einreichungen, enthält jedoch keine wesentlichen Details zu den Beschäftigungsbedingungen oder den Text der Pressemitteilung im Haupttext der Einreichung.

Evolus, Inc. أبلغت عن حدث هام في 8 سبتمبر/أيلول 2025 عبر تقرير حالي على النموذج 8-K يشير إلى كشفين إجرائيين.

أولاً، يشير filing إلى اتفاقية التوظيف موصوفة كالمرفق 10.11 في نموذج S-1 للشركة المقدم في 25 يناير 2018، ويذكر أن نسخة كاملة من تلك الاتفاقية ستُقدم كمرفق في التقرير الربعي للربع المنتهي في 30 سبتمبر 2025. ثانيًا، قدم Evolus بيانًا صحفيًا كـ Exhibit 99.1 يعلن عن أمور معينة موصوفة في مكان آخر في الإيداع؛ وقد تم توفير المرفق ولكنه ليس "مُقدَّمًا" لأغراض المسؤولية وفق القسم 18.

يحتوي التقرير الحالي على إشارات إلى المرافق الإجرائية وتوقيت لتقديم المرافق في وقت لاحق، ولكنه لا يتضمن تفاصيل جوهرية حول شروط التوظيف أو نص البيان الصحفي في متن الإيداع.

Positive
  • None.
Negative
  • None.

Evolus, Inc. ha comunicato un evento rilevante il 8 settembre 2025 tramite un Current Report on Form 8-K che segnala due divulgazioni di procedura.

In primo luogo, il deposito fa riferimento a un Contratto di Lavoro descritto come Allegato 10.11 al modulo S-1 della società presentato il 25 gennaio 2018, e afferma che una copia completa di quel Contratto di Lavoro sarà depositata come allegato al report trimestrale per il trimestre chiuso il 30 settembre 2025. In secondo luogo, Evolus ha fornito un comunicato stampa come Exhibit 99.1 annunciando determinate questioni descritte altrove nel deposito; l’esibizione è fornita ma non è filed per fini di responsabilità ai sensi della Sezione 18.

Il current report contiene riferimenti procedurali agli exhibit e tempi per ulteriori depositi, ma non include dettagli sostanziali sui termini di impiego o sul testo del comunicato stampa all'interno del corpo del deposito.

Evolus, Inc. informó un hecho material el 8 de septiembre de 2025 a través de un Current Report on Form 8-K que señala dos divulgaciones de procedimiento.

En primer lugar, la presentación hace referencia a un Acuerdo de Empleo descrito como el Anexo 10.11 al formulario S-1 de la compañía presentado el 25 de enero de 2018, y afirma que una copia completa de ese Acuerdo de Empleo se presentará como anexo al informe trimestral para el trimestre terminado el 30 de septiembre de 2025. En segundo lugar, Evolus facilitó un comunicado de prensa como Exhibit 99.1 anunciando ciertos asuntos descritos en otro lugar de la presentación; el anexo se facilita pero no se "presenta" para fines de responsabilidad de la Sección 18.

El informe actual contiene referencias a los anexos procedimentales y el calendario para presentaciones de anexos posteriores, pero no incluye detalles sustantivos de los términos de empleo ni del texto del comunicado de prensa dentro del cuerpo de la presentación.

Evolus, Inc.는 2025년 9월 8일 에 중요한 사건을 현재 보고서인 Form 8-K를 통해 보고했으며, 두 가지 절차적 공시를 주목합니다.

첫째, 제출서는 회사의 2018년 1월 25일에 제출된 Form S-1의 부록 10.11로 설명된 고용 계약을 참조하며, 이 고용 계약의 전체 사본이 2025년 9월 30일 분기말에 해당하는 분기 보고서의 부록으로 제출될 것이라고 명시합니다. 둘째, Evolus는 해당 서류에 기재된 일부 사항을 발표하는 Exhibit 99.1의 보도자료를 제공했습니다; 이 부속서는 제공되지만 제18조 책임 목적상 "파일링"되지는 않습니다.

현재 보고서는 절차적 부속서 참조와 후속 부속서 제출 시기를 포함하고 있지만 고용 조건의 실질적 세부사항이나 본문 내의 보도자료 텍스트는 포함하고 있지 않습니다.

Evolus, Inc. a annoncé un fait material le 8 septembre 2025 via un Current Report on Form 8-K indiquant deux divulgations procédurales.

Premièrement, le dépôt fait référence à un Contrat de travail décrit comme l’Exhibit 10.11 du formulaire S-1 de la société déposé le 25 janvier 2018, et affirme qu’une copie complète de ce Contrat de travail sera déposée comme pièce jointe au rapport trimestriel pour le trimestre se terminant le 30 septembre 2025. Deuxièmement, Evolus a fourni un communiqué de presse en tant que Exhibit 99.1 annonçant certains points décrits ailleurs dans le dépôt; l’exposition est fournie mais n’est pas « déposée » à des fins de responsabilité en vertu de la Section 18.

Le rapport actuel contient des références d’exhibits procéduraux et le calendrier des dépôts ultérieurs, mais ne comprend pas les détails substantiels des termes d’emploi ni le texte du communiqué de presse dans le corps du dépôt.

Evolus, Inc. meldete am 8. September 2025 eine materielle Angelegenheit über einen Current Report on Form 8-K, der zwei verfahrensrechtliche Offenlegungen festhält.

Erstens verweist die Einreichung auf eine Anstellungsvereinbarung, beschrieben als Exhibit 10.11 des Unternehmens-Formulars S-1, das am 25. Januar 2018 eingereicht wurde, und erklärt, dass eine vollständige Kopie dieser Anstellungsvereinbarung als Anhang dem Quartalsbericht für das zum 30. September 2025 endende Zeitraum beigefügt wird. Zweitens stellte Evolus eine Pressemitteilung als Exhibit 99.1 zur Verfügung, die bestimmte dort anderswo in der Einreichung beschriebene Angelegenheiten ankündigt; der Anhang wird zwar bereitgestellt, ist aber nicht für Abschnitt 18 Haftungszwecke "eingegeben".

Der aktuelle Bericht enthält verfahrensbezogene Verweisungen auf Anhänge und den Zeitplan für spätere Einreichungen, enthält jedoch keine wesentlichen Details zu den Beschäftigungsbedingungen oder den Text der Pressemitteilung im Haupttext der Einreichung.

0001570562false00015705622025-09-082025-09-08

 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 8, 2025
EVOLUS, INC.
(Exact name of registrant as specified in its charter)
Delaware
001-38381
46-1385614
(State or other jurisdiction
of incorporation)
(Commission File Number)
(I.R.S. Employer
Identification No.)

520 Newport Center Drive, Suite 1200
Newport Beach, California 92660
(Address of principal executive offices) (Zip Code)

(949) 284-4555
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of ClassTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.00001 per shareEOLS
The Nasdaq Stock Market LLC
(Nasdaq Global Market)


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.





Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Appointment of Chief Financial Officer

On September 8, 2025, Evolus, Inc. (the “Company”) announced that, effective September 8, 2025, its Board of Directors (the “Board”) appointed Tatjana Mitchell to serve as the Company’s Chief Financial Officer.

Tatjana Mitchell, age 47, served as the Senior Vice President, Finance of Experian North America since April 2023. From May 2019 to March 2023, Ms. Mitchell served as the Chief Financial Officer for Experian North America Consumer Services. From December 2015 to May 2019, Ms. Mitchell served as the Vice President of Finance and Chief Financial Officer of Zulily, an online retailer and subsidiary of Qurate Retail. Ms. Mitchell holds a B.S. in Business Administration from Towson University and an MBA from the Wharton School at the University of Pennsylvania.

There are no arrangements or understandings between Ms. Mitchell and any other persons pursuant to which Ms. Mitchell was selected to be an officer of the Company. Ms. Mitchell does not have any family relationships subject to disclosure under Item 401(d) of Regulation S-K promulgated by the Securities and Exchange Commission (the “SEC”) or any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

The Company and Ms. Mitchell entered into an employment agreement (the “Employment Agreement”) effective as of Ms. Mitchell’s scheduled first day of employment with the Company, September 8, 2025 (the “Start Date”), setting forth the terms and conditions of her employment as the Company’s Chief Financial Officer. Under the Employment Agreement, the Company shall pay Ms. Mitchell a base salary at the annualized rate of $490,000. Ms. Mitchell will also receive a one-time signing bonus of $100,000, subject to repayment if Ms. Mitchell’s employment ceases (other than as a result of a termination by the Company without “Cause” or by Ms. Mitchell for “Good Reason” as specified in the Employment Agreement) prior to the first anniversary of her employment commencement date and subject to 50% repayment if such a termination of her employment occurs after the first anniversary, but before the second anniversary, of her employment commencement date. Ms. Mitchell is also eligible to receive an annual incentive bonus, as determined by the Board in its reasonable discretion and taking performance into account, with a target annual bonus opportunity equal to 55% of her base salary (the “Annual Bonus”).

In accordance with the Employment Agreement, on or promptly after the Start Date, Ms. Mitchell will be granted (i) a stock option (the “Option”) to purchase shares of the Company’s common stock and (ii) an award of Company restricted stock units (“RSUs”). The number of shares of Company common stock subject to the Option will be determined by dividing $750,000 by the Black-Scholes value of such an option (as determined by the Company using its regular stock option valuation methodology and assumptions) as of the Start Date. The per share exercise price of the Option will equal the Nasdaq closing price (in regular trading) of a share of Company common stock on the date of grant of the Option (or as of the last Nasdaq trading day preceding the date of grant of the Option if such date of grant is not a Nasdaq trading day). The number of shares of Company common stock subject to the RSUs will equal $750,000 divided by the 30-day average closing price of a share of Company common stock as of the Start Date.

The Option will be scheduled to vest in equal annual installments over four years commencing with the date of grant of the award and the RSUs will be scheduled to vest as to 50% of the award on the third anniversary of the date of grant and as to the remaining 50% of the award on the fourth anniversary of the date of grant of the award, subject in each case to Ms. Mitchell’s continuing employment with the Company through the applicable vesting date. The Option and the RSUs will each be granted as inducement grants in accordance with Nasdaq Listing Rule 5635(c)(4) as an inducement material to Ms. Mitchell’s acceptance of employment with the Company and will be awarded under the Company’s 2023 Inducement Incentive Plan.

Under the Employment Agreement and subject to Ms. Mitchell executing a release of claims, upon the Company’s termination of Ms. Mitchell’s employment without cause or if Ms. Mitchell resigns for Good Reason, the Company is required to pay (i) severance to Ms. Mitchell equal to twelve months of her base salary paid in a lump sum plus a pro-rated portion of her annual bonus payable for the calendar year in which such termination occurs, (ii) a lump sum payment of the amount Ms. Mitchell would be expected to pay in order to continue medical coverage pursuant to COBRA for twelve months and (iii) a lump sum payment of Fifteen Thousand Dollars ($15,000) as outplacement assistance. If, however, such a termination of Ms. Mitchell’s employment occurs within three months prior to, upon, or within twelve months after a “change in control” event (as defined in the Employment Agreement), Ms. Mitchell is instead entitled, subject to Ms. Mitchell executing a release of claims, to the following (i) severance equal to eighteen months of her base salary paid in a lump sum plus 100% of her annual target bonus payable for the calendar year in which such termination occurs, (ii) a lump sum payment of the amount Ms. Mitchell would be expected to pay in order to continue medical coverage pursuant to COBRA for eighteen months, (iii) a lump sum




payment of Fifteen Thousand Dollars ($15,000) as outplacement assistance and (iv) accelerated vesting of all time and service based vesting conditions applicable to her outstanding Company equity awards.

In connection with her employment by the Company, Ms. Mitchell will also enter into the Company’s standard indemnification agreement for its executive officers and directors, the form of which is filed as Exhibit 10.11 to the Company’s Registration Statement on Form S-1 filed with the SEC on January 25, 2018.

The foregoing description of the Employment Agreement does not purport to be complete and is qualified in its entirety by reference to the complete Employment Agreement, a copy of which will be filed with the SEC as an exhibit to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025.

Item 7.01    Regulation FD Disclosure.

On September 8, 2025, the Company issued a press release announcing certain of the matters described in Item 5.02 of this Current Report on Form 8-K. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

As provided in General Instruction B.2 of Form 8-K, the information in this Item 7.01 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.




Item 9.01    Financial Statements and Exhibits.

(d)    Exhibits.

Exhibit Number
Description
99.1
Press Release of Evolus, Inc., dated September 8, 2025
104Cover Page Interactive Data File (embedded within the Inline XBRL document)




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Evolus, Inc.
Dated: September 8, 2025
/s/ David Moatazedi
David Moatazedi
President and Chief Executive Officer

FAQ

What did Evolus (EOLS) disclose in the 8-K filed September 8, 2025?

The company disclosed that it furnished a press release as Exhibit 99.1 and referenced an Employment Agreement (Exhibit 10.11 from the Form S-1 dated January 25, 2018), which will be filed later as an exhibit to the Quarterly Report for the quarter ended September 30, 2025.

Is the press release included as a filed exhibit in the 8-K?

No. The press release was furnished as Exhibit 99.1, and the filing states that furnished items are not deemed "filed" for purposes of Section 18 of the Exchange Act.

Will the Employment Agreement be available now in the 8-K?

No. The filing states a complete copy of the Employment Agreement will be filed later as an exhibit to the Quarterly Report for the period ended September 30, 2025.

Does the 8-K include details of the employment terms or the press release content?

No. The 8-K references the Employment Agreement and furnishes the press release exhibit but does not include substantive employment terms or the press release text within the body of the filing.

What does the filing say about liability for the furnished exhibit?

The filing notes that information in Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for Section 18 liability and will not be incorporated by reference into registration statements unless expressly stated.
Evolus

NASDAQ:EOLS

EOLS Rankings

EOLS Latest News

EOLS Latest SEC Filings

EOLS Stock Data

436.63M
52.16M
11.81%
91.06%
17.98%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
NEWPORT BEACH